BL-1743

N/A

Report date: 2022/08/26 10:54:20
NME

Base Information

Drug NameBL-1743
Drug Alias Name2-[3-azaspiro (5,5)undecanol]-2-imidazolineBL-1743
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProteins inhibitors
TargetsProteins
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A